• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico.在墨西哥西北部的 8 个本土人群中,混合成分对 CYP2C9*2 等位基因频率的影响。
Pharmacogenomics J. 2013 Dec;13(6):567-72. doi: 10.1038/tpj.2012.52. Epub 2013 Jan 29.
2
CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards.人群中 CYP2C9 等位基因频率的差异:墨西哥-梅斯蒂索人、墨西哥-特佩胡阿尼人以及西班牙人。
Pharmacogenomics J. 2011 Apr;11(2):108-12. doi: 10.1038/tpj.2010.29. Epub 2010 May 11.
3
Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis.CYP2C9和VKORC1基因多态性对华法林治疗患者出血并发症风险的影响:一项系统评价和荟萃分析。
Int J Cardiol. 2013 Oct 9;168(4):4234-43. doi: 10.1016/j.ijcard.2013.07.151. Epub 2013 Aug 7.
4
CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database.汉族人群中CYP2C9基因多态性分析:构建最大的等位基因频率数据库。
Pharmacogenomics J. 2014 Feb;14(1):85-92. doi: 10.1038/tpj.2013.2. Epub 2013 Feb 12.
5
Family-centred interventions for Indigenous early childhood well-being by primary healthcare services.以初级医疗保健服务为中心的家庭干预措施,促进土著儿童早期的身心健康。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD012463. doi: 10.1002/14651858.CD012463.pub2.
6
CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.华法林治疗患者的CYP2C9基因变异、药物剂量与出血风险:一项HuGEnet系统评价与荟萃分析
Genet Med. 2005 Feb;7(2):97-104. doi: 10.1097/01.gim.0000153664.65759.cf.
7
Influence of CYP2C9 genetic variants on gastrointestinal bleeding associated with nonsteroidal anti-inflammatory drugs: a systematic critical review.CYP2C9 基因变异对非甾体抗炎药相关胃肠道出血的影响:系统评价。
Pharmacogenet Genomics. 2011 Jul;21(7):357-64. doi: 10.1097/FPC.0b013e328346d2bb.
8
Understanding patient pathways to Mother and Baby Units: a longitudinal retrospective service evaluation in the UK.了解患者通往母婴病房的路径:英国一项纵向回顾性服务评估
Health Soc Care Deliv Res. 2025 Jul 16:1-17. doi: 10.3310/GDVS2427.
9
Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.CYP2C9 和 VKORC1 对患者华法林反应的影响:系统评价和荟萃分析。
PLoS One. 2012;7(8):e44064. doi: 10.1371/journal.pone.0044064. Epub 2012 Aug 29.
10
Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement--a systematic review and meta analysis.VKORC1 基因多态性对个体间和种族间华法林剂量需求的影响——系统评价和荟萃分析。
Thromb Res. 2010 Apr;125(4):e159-66. doi: 10.1016/j.thromres.2009.10.017. Epub 2009 Nov 25.

引用本文的文献

1
Molecular Ancestry Across Allelic Variants of , , , , , , and in Mexican-Mestizo DMT2 Patients.墨西哥梅斯蒂索2型糖尿病患者中,关于……、……、……、……、……、……和……等位基因变体的分子谱系。 (原文中部分基因名称未完整给出)
Biomedicines. 2025 May 9;13(5):1156. doi: 10.3390/biomedicines13051156.
2
Prediction of CYP-mediated silybin A-losartan pharmacokinetic interactions using physiological based pharmacokinetic modeling.使用基于生理的药代动力学模型预测细胞色素P450介导的水飞蓟宾A-氯沙坦药代动力学相互作用。
J Pharmacokinet Pharmacodyn. 2022 Jun;49(3):311-323. doi: 10.1007/s10928-022-09804-0. Epub 2022 Jan 21.
3
Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon.
巴西亚马逊地区原住民中药物相关基因的遗传多样性
Pharmgenomics Pers Med. 2021 Jan 22;14:117-133. doi: 10.2147/PGPM.S274741. eCollection 2021.
4
Influence of Genetic Admixture Components on Allele-Associated Hypertension in Amerindian Populations From Northwest Mexico.遗传混合成分对墨西哥西北部美洲印第安人群中等位基因相关高血压的影响。
Front Pharmacol. 2020 May 11;11:638. doi: 10.3389/fphar.2020.00638. eCollection 2020.
5
The effect of , , and polymorphism in patients under warfarin therapy in city of Kermanshah.克尔曼沙赫市接受华法林治疗的患者中 、 和 基因多态性的影响
Res Pharm Sci. 2018 Aug;13(4):377-384. doi: 10.4103/1735-5362.235165.
6
P450 Pharmacogenetics in Indigenous North American Populations.北美原住民群体中的细胞色素P450药物遗传学
J Pers Med. 2018 Feb 1;8(1):9. doi: 10.3390/jpm8010009.
7
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.CYP2C9的药物基因组学:功能与临床考量
J Pers Med. 2017 Dec 28;8(1):1. doi: 10.3390/jpm8010001.

在墨西哥西北部的 8 个本土人群中,混合成分对 CYP2C9*2 等位基因频率的影响。

Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico.

机构信息

Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional del IPN Unidad Durango, Academia de Genómica, CIIDIR-IPN, Durango, México.

出版信息

Pharmacogenomics J. 2013 Dec;13(6):567-72. doi: 10.1038/tpj.2012.52. Epub 2013 Jan 29.

DOI:10.1038/tpj.2012.52
PMID:23358499
Abstract

We previously documented the lowest frequency of CYP2C92 in Mexican indigenous Tepehuanos followed by Mestizos and Mexican-Americans populations, suggesting a negative correlation between the CYP2C92 frequency and the degree of Asian ancestry in indigenous Americans. We determined the influence of ethnic admixture components on the CYP2C9 allele distribution in 505 Amerindian from eight indigenous populations through genotyping CYP2C92, 3 and 6 alleles by real-time PCR and molecular evaluation of ancestry. The frequencies for CYP2C92 were 0.026 in Seris and 0.057 in Mayos, being higher than in Asians (P<0.001). CYP2C93 was found in Tarahumaras (0.104), Mayos (0.091), Tepehuanos (0.075), Guarijíos (0.067), Huicholes (0.033) and Coras (0.037), with East Asians having lower frequencies than the former three groups (P<0.001). CYP2C96 was not found. The frequency of CYP2C9*2 was lower in Amerindians than in European populations, and higher than their Asian ancestors. The presence of this allele in ethnic groups in Mexico can be explained by European admixture.

摘要

我们之前记录了墨西哥本土特佩万诺人的 CYP2C92 频率最低,其次是梅斯蒂索人和墨西哥裔美国人,这表明 CYP2C92 频率与美洲原住民中亚裔血统的程度呈负相关。我们通过实时 PCR 对 CYP2C92、3 和6 等位基因进行基因分型,并通过对祖先的分子评估,确定了种族混合成分对 505 名来自 8 个原住民群体的美洲印第安人 CYP2C9 等位基因分布的影响。CYP2C92 的频率在 Seris 为 0.026,在 Mayo 为 0.057,高于亚洲人(P<0.001)。Tarahumaras(0.104)、Mayos(0.091)、Tepehuanos(0.075)、Guarijíos(0.067)、Huicholes(0.033)和 Coras(0.037)中发现了 CYP2C93,东亚人的频率低于前三个群体(P<0.001)。未发现 CYP2C96。美洲印第安人的 CYP2C9*2 频率低于欧洲人群,高于其亚洲祖先。该等位基因在墨西哥的族群中存在,可以用欧洲人的混合来解释。